Carnoy's液在颌骨囊性病变辅助治疗中的应用

doi:10.13701/j.cnki.kqyxyj.2023.12.004

口腔医学研究 ›› 2023, Vol. 39 ›› Issue (12): 1046-1049.DOI: 10.13701/j.cnki.kqyxyj.2023.12.004

Carnoy's液在颌骨囊性病变辅助治疗中的应用

满其文^1*, 王含琪²

1.武汉大学口腔医院口腔颌面外科湖北武汉 430079;
2.武汉大学口腔医学院口腔基础医学省部共建国家重点实验室培育基地和口腔生物医学教育部重点实验室湖北武汉 430079

收稿日期:2023-03-09 出版日期:2023-12-28 发布日期:2023-12-25
通讯作者: * 满其文,E-mail:manqiwen@whu.edu.cn
作者简介:满其文(1990~ ),男,济南人,副主任医师,博士,主要从事牙源性囊肿及肿瘤的发病机制研究。
基金资助:
国家自然科学基金(编号:82001066)

Application of Carnoy's Solution in Adjuvant Treatment of Jaw Cystic Lesions: A Review

MAN Qiwen^1*, WANG Hanqi²

1. Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Wuhan University, Wuhan 430079, China;
2. State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China

Received:2023-03-09 Online:2023-12-28 Published:2023-12-25

摘要/Abstract

摘要： 牙源性角化囊肿和单囊型成釉细胞瘤是常见的颌骨良性病变,具有较强的局部侵袭性。好发于青少年,且多见于颌骨后分或升支部位。单纯的病变刮治或开窗减压术处理后,有较高的术后复发率,而手术联合辅助治疗例如物理或化学处理可显著降低其复发率。Carnoy's液是临床上应用较早的化学固定剂,在颌骨囊性病变尤其是牙源性角化囊肿辅助治疗中的作用已得到广泛验证,但目前部分临床医生对Carnoy's液临床应用的适应证和安全性仍存在顾虑。本综述回顾Carnoy's液及其改良制剂的作用原理、临床应用的有效性及安全性问题。

关键词: Carnoy's液, 牙源性角化囊肿, 单囊成釉细胞瘤, 复发, 辅助治疗

Abstract: Odontogenic keratocysts and unicystic ameloblastomas are common benign lesions of the jaw but are locally aggressive. The above-mentioned lesions are all prone to occur in adolescents, and are more common in the posterior part of the jaw or the ascending ramus. Due to the limited field of view in the operation area and the high invasion ability of the lesion itself, there is often a high postoperative recurrence rate after simple curettage or decompression, and surgical methods combined with adjuvant therapy such as physical or chemical treatment can significantly reduce the recurrence. Carnoy's solution is a chemical fixative used early in clinical practice. Carnoy's solution has been widely verified in the adjuvant treatment of cystic lesions of the jaw, especially odontogenic keratocyst. However, some clinicians still have concerns about the indications and safety of the clinical application of Carnoy's solution. This review introduces the principle, effectiveness, and safety of Carnoy's solution and its modified patterns in treatment of jaw cystic lesions.

Key words: Carnoy's solution, odontogenic keratocyst, ameloblastoma, recur, adjuvant treatment

满其文, 王含琪. Carnoy's液在颌骨囊性病变辅助治疗中的应用[J]. 口腔医学研究, 2023, 39(12): 1046-1049.

MAN Qiwen, WANG Hanqi. Application of Carnoy's Solution in Adjuvant Treatment of Jaw Cystic Lesions: A Review[J]. Journal of Oral Science Research, 2023, 39(12): 1046-1049.

参考文献

[1] 段聪聪,韩冰.颌骨囊性病变相关手术治疗的发展现状[J].口腔医学研究,2020,36(10):898-901.
[2] Gomes IP, Bastos VC, Guimarães LM,et al. The molecular basis of odontogenic cysts and tumours? [J]. J Oral Pathol Med, 2023, 52(4): 351-356.
[3] Ecker J, Horst Rt, Koslovsky D. Current role of Carnoy's solution in treating keratocystic odontogenic tumors [J]. J Oral Maxillofac Surg, 2016, 74(2):278-282.
[4] Lebedev VV, Butsan SB. The use of Carnoy’s solution and its modifications for reducing the number of recurrences after surgical removal of keratocystic odontogenic tumors and ameloblastomas: A systematic review [J]. Moscow Univ Biol Sci Bull, 2019, 74(2):108-116.
[5] Cutler EC, Zollinger R. The use of sclerosing solutions in the treatment of cysts and fistulae [J]. Am J Surg, 1933, 19(3):411-418.
[6] Wahab MM, Abdul DPU. Carnoy's solution as a surgical medicament in the treatment of keratocystic odontogenic tumour [J]. Int J Pharma Bio Sci, 2014, 5(1):B492-B495.
[7] Puchtler H, Waldrop FS, Conner HM, et al. Carnoy fixation: practical and theoretical considerations [J]. Histochemie, 1968, 16 (4):361-371.
[8] Carvalho FSR, Feitosa VP, da Cruz Fonseca SG, et al. Physicochemical and rheological characterization of different Carnoy's solutions applied in oral and maxillofacial surgery [J]. J Raman Spectrosc, 2017, 48 (10):1375-1384.
[9] Carvalho F, Feitosa V, Silva P, et al. Evaluation of different therapeutic Carnoy's formulations on hard human tissues: A Raman microspectroscopy, microhardness, and scanning electron microscopy study [J]. J Craniomaxillofac Surg, 2018, 46(5):749-758.
[10] Dashow JE, McHugh JB, Braun TM, et al. Significantly decreased recurrence rates in keratocystic odontogenic tumor with simple enucleation and curettage using Carnoy's versus modified Carnoy's solution [J]. J Oral Maxillofac Surg, 2015, 73(11):2132-2135.
[11] Karacai R, Uluğ B, Kodaz T, et al. Regarding "Significantly decreased recurrence rates in keratocystic odontogenic tumor with simple enucleation and curettage using Carnoy's versus modified Carnoy's solution" [J]. J Oral Maxillofac Surg,2016, 74(6):1103-1104.
[12] Donnelly LA, Simmons TH, Blitstein BJ, et al. Modified Carnoy's compared to Carnoy's solution is equally effective in preventing recurrence of odontogenic keratocysts [J]. J Oral Maxillofac Surg,2021, 79(9):1874-1881.
[13] Janas-Naze A, Zhang W, Szuta M. Modified Carnoy's versus Carnoy's solution in the management of odontogenic keratocysts-A single center experience [J]. J Clin Med, 2023, 12(3):1133.
[14] Man QW. A survey on the application of Carnoy's solution in China [J]. Adv Oral Maxillofac Surg,2023,10:100412.
[15] Fidele NB, Zhao YF, Wu TF, et al.Treatment of multiple odontogenic keratocysts involving Chinese patients [J]. J Oral Maxillofac Surg, 2019, 77(10):2044-2054.
[16] Malci A, Juki S, Ani I, et al. Alterations of FHIT and P53 genes in keratocystic odontogenic tumor, dentigerous and radicular cyst [J]. J Oral Pathol Med, 2008, 37(5):294-301.
[17] 刘冰,何悦,彭歆,等.牙源性角化囊肿诊疗中国专家共识[J].中国口腔颌面外科杂志,2022,20(3):209-218.
[18] Johnson N, Batstone M, Savage N. Management and recurrence of keratocystic odontogenic tumor: a systematic review [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2013, 116(4):e271-e276.
[19] Chrcanovic B, Gomez R. Recurrence probability for keratocystic odontogenic tumors: An analysis of 6427 cases [J]. J Craniomaxillofac Surg,2017, 45(2):244-251.
[20] Fidele NB, Zheng YY, Zhao Y, et al. Recurrence of odontogenic keratocysts and possible prognostic factors: Review of 455 patients [J]. Med Oral Patol Oral Cir Bucal, 2019, 24(4):e491-e501.
[21] Effiom OA, Ogundana OM, Akinshipo AO, et al. Ameloblastoma: current etiopathological concepts and management [J]. Oral Dis, 2018, 24(3):307-316.
[22] El-Naggar AK CJ, Grandis JR, Takata T, et al. WHO classification of head and neck tumours. El-Naggar AK.WHO Classification of Tumours[S].4th edition.9. Lyon, France: World Health Organization, 2017: 203-260.
[23] Lee P, Samman N, Ng I. Unicystic ameloblastoma--use of Carnoy's solution after enucleation [J]. Int J Oral Maxillofac Surg, 2004, 33(3):263-267.
[24] Rajeshkumar BP, Rai KK, Geetha NT, et al. Carnoy's in aggressive lesions: Our experience [J]. J Maxillofac Oral Surg, 2013, 12(1):42-47.
[25] Liu C, Samani M, Kwok J, et al. Conservative management of botryoid odontogenic cysts using Carnoy's solution [J]. Br J Oral Maxillofac Surg, 2020, 58(2):245-247.
[26] Frerich B, Cornelius CP, Wiethölter H. Critical time of exposure of the rabbit inferior alveolar nerve to Carnoy's solution [J]. J Oral Maxillofac Surg, 1994, 52(6):599-606.
[27] Saulacic N, Stajcic Z, Stojcev Stajcic L, et al. Effects of Carnoy's solution on blood vessels of the axillary fossa of rats [J]. Int J Oral Maxillofac Surg, 2009, 38(8):876-879.
[28] Sivanmalai S, Kandhasamy K, Prabu N, et al. Carnoy's solution in the mangement of odontogenic keratocyst [J]. J Pharm Bioallied Sci, 2012, 4(Suppl 2):S183-S185.
[29] Jo HJ, Kim HY, Kang DC, et al. A clinical study of inferior alveolar nerve damage caused by Carnoy's solution used as a complementary therapeutic agent in a cystic lesion [J]. Maxillofac Plast Reconstr Surg, 2020, 42(1):16.
[30] Carvalho FSR, Feitosa VP, Silva PGB, et al. Evaluation of different therapeutic Carnoy's formulations on hard human tissues: A Raman microspectroscopy, microhardness, and scanning electron microscopy study [J]. J Craniomaxillofac Surg, 2018, 46(5):749-758.
[31] Slusarenko da Silva Y, Stoelinga PJW, Naclério-Homem MG. Immediate and late effects of Carnoy's solution on the mandibular bone of Wistar rats [J]. Oral Surg, 2019, 12(2):104-109.
[32] Ribeiro Junior O, Borba AM, Alves CA, et al. Keratocystic odontogenic tumors and Carnoy's solution: results and complications assessment [J]. Oral Dis, 2012,18(6):548-557.

Carnoy's液在颌骨囊性病变辅助治疗中的应用

Application of Carnoy's Solution in Adjuvant Treatment of Jaw Cystic Lesions: A Review

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	周洁, 晏全红, 曾晓云, 金松. 压力知觉量表在复发性阿弗他溃疡中的信度与效度[J]. 口腔医学研究, 2023, 39(10): 923-927.
[2]	刘佳文, 王汉明, 杨湘晖, 范志龙, 贺晓明, 甘雨娟, 刘荷婧. 基于TOLL受体及PI3K/AKT/mTOR信号通路探讨愈口宁对复发性阿弗他溃疡大鼠炎性因子的调节[J]. 口腔医学研究, 2023, 39(1): 68-73.
[3]	柯晓菁, 金讴, 闫福华, 李艳芬, 李厚轩. 234例牙龈瘤患者的临床特征及复发防范分析[J]. 口腔医学研究, 2022, 38(5): 429-435.
[4]	宗颖睿, 秦红霞, 候珍珍, 李晓娜, 胡文彬, 张晨. 术前免疫炎症指数和列线图对腺样囊性癌患者预后的预测价值[J]. 口腔医学研究, 2022, 38(12): 1128-1133.
[5]	胡晓菁, 林璐, 黄臻, 张停停, 刘清, 史彦. 益生菌芦荟发酵凝胶治疗复发性阿弗他溃疡的疗效及对口腔微生物群落的影响[J]. 口腔医学研究, 2022, 38(1): 85-89.
[6]	高小兰, 王汉明. Th细胞相关细胞因子在复发性口腔溃疡中的研究进展[J]. 口腔医学研究, 2021, 37(5): 397-400.
[7]	田媛, 周刚, 关晓兵, 谭劲, 刘关键, 隋秋丽, 李佳, 林梅, 周红梅. 石辛含片治疗复发性口疮(胃火上炎证)的随机双盲安慰剂对照多中心临床试验研究[J]. 口腔医学研究, 2021, 37(2): 167-172.
[8]	范腾飞, 任振虎, 杨雯君, 张胜, 胡镜宙, 吴汉江, 张陈平. 胸背动脉穿支皮瓣修复口腔癌复发后软组织缺损的疗效分析[J]. 口腔医学研究, 2021, 37(11): 1036-1038.
[9]	高睿, 闫伟军, 安晶涛, 宋冰, 邵玶. miR-146a激动剂对正畸复发过程牙周组织中炎症因子和IRAK1、TRAK6表达的影响[J]. 口腔医学研究, 2020, 36(5): 469-472.
[10]	李艺, 窦圣金, 张霖, 李烿烿, 朱国培. PD-1抗体联合抗血管生成靶向治疗在晚期复发转移头颈部肿瘤中的探索研究[J]. 口腔医学研究, 2020, 36(2): 158-163.
[11]	张文杰, 管翠强. 复发性阿弗他溃疡与DNA甲基化的关系[J]. 口腔医学研究, 2020, 36(12): 1095-1098.
[12]	康永歌, 张锡忠, 彭朋, 董晓曦, 曹扬, 冉宇婷, 冯翀, 苗倩. 低能量激光对大鼠牙移动后复发的影响[J]. 口腔医学研究, 2018, 34(10): 1104-1107.
[13]	李娟，刘宗响，段宁，孙鹏，王文梅. Nd:YAG激光、CO₂激光局部治疗轻型复发性阿弗他溃疡短期疗效比较研究[J]. 口腔医学研究, 2017, 33(9): 970-973.
[14]	苏红影, 李维善, 刘岩, 王欣荣, 张爽爽. 复发性阿弗他溃疡患者焦虑与唾液皮质醇和脱氢表雄酮水平的相关性研究[J]. 口腔医学研究, 2017, 33(2): 221-224.
[15]	阮欢欢,王文梅,王翔,段宁,蒋红柳,白杨,黎景景,钱雅洁,周倩. 小剂量短疗程泼尼松治疗顽固性复发性阿弗他溃疡的疗效及免疫改变[J]. 口腔医学研究, 2017, 33(1): 47-50.